Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
7
×
national top stories
biotech
boston blog main
boston top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
clinical trials
new york top stories
startups
deals
drugs
pfizer
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
amgen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
investing
national
new york
san diego
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
What
drug
7
×
year
7
×
medicines
disease
new
big
ceo
companies
fda
infectious
million
therapeutics
therapies
aces
adds
ago
akcea
alliance
alnylam
alzheimer’s
amyloidosis
announced
approval
approved
areas
arguments
athena
attr
available
bacteria
battle
bio
biopharma
biosciences
biotech
bio’s
brii
business
cancer
chief
Language
unset
Current search:
drug
×
" national blog main "
×
year
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push